Clinical Trials on Eye Abnormalities

Total 39322 results

Pfizer

Completed

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Eye Diseases | Macular Degeneration | Retinal Degeneration | Age-Related Maculopathies | Age-Related Maculopathy

United States
Beijing Tongren Hospital

Recruiting

Safety Study of rAAV2/8-hCYP4V2 in Patients With Bietti's Crystalline Dystrophy (BCD)

Bietti's Crystalline Dystrophy

China
Bionic Sight LLC

Recruiting

BS01 in Patients With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Marian Macsai, MD

Recruiting

Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy

Fuchs' Endothelial Dystrophy

United States
Sanofi

Active, not recruiting

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Stargardt's Disease

United States, France
Hospices Civils de Lyon

Completed

Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity

Marfan Syndrome | Ectopia Lentis

France
Amgen

Not yet recruiting

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Thyroid Eye Disease
Amgen

Recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Thyroid Eye Disease

United States
Assiut University

Not yet recruiting

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

Thyroid Eye Disease
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Belgium, Latvia, Hungary, Spain, Slovakia, Puerto Rico, New Zealand, Turkey
Horizon Therapeutics USA, Inc.

Completed

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Thyroid Eye Disease

United States
Iran University of Medical Sciences

Withdrawn

The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease

Thyroid Eye Disease

Iran, Islamic Republic of
University of California, Los Angeles

Terminated

Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease (HALR)

Thyroid Eye Disease

United States
University of Pittsburgh

Terminated

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease (BetTeRTED)

Thyroid Eye Disease

United States
L.V. Prasad Eye Institute
Allergan

Recruiting

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Congenital Hereditary Endothelial Dystrophy of Cornea

India
ViGeneron GmbH

Recruiting

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

Retinitis Pigmentosa

Germany
Chigenovo Co., Ltd

Recruiting

Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Bietti's Crystalline Dystrophy

China
Centre Hospitalier National d'Ophtalmologie des...

Recruiting

Mobility Protocol Adapted for Advanced Visually Impaired Subjects (PROMA)

Pigmentary Retinopathy

France
Oregon Health and Science University

Recruiting

OCT in Diagnosis of Irregular Corneas

Corneal Opacity | Keratoconus | Corneal Dystrophy

United States
University Eye Hospital, Freiburg

Completed

Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea (EDEMAS)

Fuchs' Endothelial Dystrophy

Germany
Centre Hospitalier National d'Ophtalmologie des...

Unknown

Impact of Visual Field Restriction on Visual Exploration (REVE)

Pigmentary Retinopathy

France
Gemini Therapeutics, Inc.

Terminated

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

Macular Degeneration | Retinal Degeneration | Neovascular Age-related Macular Degeneration | Retinal Disease

United States
Nanoscope Therapeutics Inc.

Completed

Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa

Retinal Degeneration | Retinal Diseases | Retinitis Pigmentosa

India
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
Southwest Hospital, China

Unknown

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

Macular Degeneration | Stargardt's Macular Dystrophy

China
Horizon Therapeutics USA, Inc.

Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Thyroid Eye Disease | Chronic (Inactive) Thyroid Eye Disease

United States
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease

Thyroid Eye Disease | TED

Japan, Australia, Singapore, United States, Argentina, Germany, Italy, Hong Kong
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Sheba Medical Center

Recruiting

Tamsulosin for Thyroid Lid Retraction

Thyroid Eye Disease | Eyelid Diseases

Israel
Horizon Pharma USA, Inc.

Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC)

Thyroid Eye Disease | Graves' Orbitopathy

United States, Italy, Germany
Horizon Pharma USA, Inc.

Approved for marketing

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease (EAP)

Thyroid Eye Disease | Graves' Orbitopathy

United States
EDUARD PEDEMONTE-SARRIAS

Completed

Technique And Results In Endothelial Keratoplasty (TREK)

Fuchs' Endothelial Dystrophy | Corneal Endothelial Cell Loss

Spain
Tyrogenex
International Drug Development Institute; SynteractHCR

Terminated

X-82 to Treat Age-related Macular Degeneration

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Age-Related Macular Degeneration (AMD) | Exudative Age-related Macular Degeneration | AMD | Macular Degeneration, Age-related, 10

United States
Davinci LTD

Recruiting

Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas

Glaucoma, Open-Angle | Pseudo Exfoliation Syndrome | Suprachoroidal Space

Georgia
National Taiwan University Hospital
Alcon Research

Recruiting

3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes

Patients With Highly Myopic Eyes

Taiwan
Ohio State University
Alcon Research

Completed

Wear Experience With Daily Toric Contact Lenses Over a Long Day

Contact Lens | Astigmatism of Both Eyes

United States
Medical University of Graz

Completed

Optical Coherence Tomography Angiography (OCTA) Changes in Patients With Epiretinal Membranes (ERM) With and Without Peeling of the Internal Limiting Membrane (ILM)

Epiretinal Membrane of Both Eyes

Austria
TC Erciyes University

Recruiting

Relation Between Oculocardiac Reflex and Laryngospasm

Eye Abnormalities | Arrythmia

Turkey
Vastra Gotaland Region

Completed

Eye and Growth in Adolescents Born Moderate-to-late Preterm

Eye Abnormalities | Preterm Birth | Visual Impairment

Sweden
Maastricht University Medical Center

Not yet recruiting

The OPTIMISE Study

Intraocular Pressure | Fuchs' Endothelial Dystrophy | Pseudophakic Bullous Keratopathy
Belite Bio, Inc

Active, not recruiting

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease (DRAGON)

Stargardt Disease 1

United States, Australia, Belgium, China, France, Germany, Hong Kong, Netherlands, Switzerland, Taiwan, United Kingdom
West China Hospital

Active, not recruiting

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Stargardt Disease 1

China
Nanoscope Therapeutics Inc.

Completed

Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

Retinitis Pigmentosa | Retinal Dystrophy

United States, Puerto Rico
Nanoscope Therapeutics Inc.

Enrolling by invitation

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection (EXTEND)

Retinal Degeneration | Retinitis Pigmentosa | Retinal Disease

India
University Hospital, Strasbourg, France

Unknown

Self-confidence Study in Patients With Argus II Artificial Retina

Pigmentary Retinopathy

France
Vissum, Instituto Oftalmológico de Alicante
Hospital Universitario La Paz; Reviva Pharmaceuticals; LASER VISION CENTER IN... and other collaborators

Unknown

Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases (A-ADAS-CT-CD)

Keratoconus | Hereditary Corneal Dystrophy

Lebanon
Wenzhou Medical University

Not yet recruiting

Influence of Different Tamponade Eyes on IOL-capsular Complex

Cataract | Vitreoretinal Abnormality
National Eye Institute (NEI)

Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Retinal Disease | Genotype

United States
Walter Reed National Military Medical Center

Recruiting

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction (Teprotumumab)

Thyroid Eye Disease | Graves Ophthalmopathy | Graves Disease

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Customized Multiple Orbital Wall Decompression for Sight-threatening Graves's Ophthalmopathy

Thyroid Eye Disease

China

Clinical Trials on Eye Abnormalities

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations